Connection

Perry Molinoff to Male

This is a "connection" page, showing publications Perry Molinoff has written about Male.
Connection Strength

0.191
  1. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. Int J Impot Res. 2004 Apr; 16(2):135-42.
    View in: PubMed
    Score: 0.012
  2. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int J Impot Res. 2004 Feb; 16(1):51-9.
    View in: PubMed
    Score: 0.012
  3. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003 Jun; 994:96-102.
    View in: PubMed
    Score: 0.012
  4. Identification of ascorbate as an endogenous substance that irreversibly inhibits binding of dihydropyridine calcium channel blockers. J Neurochem. 1992 Apr; 58(4):1300-7.
    View in: PubMed
    Score: 0.005
  5. Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation. J Pharmacol Exp Ther. 1991 Oct; 259(1):337-44.
    View in: PubMed
    Score: 0.005
  6. Polyamines modulate the binding of [3H]MK-801 to the solubilized N-methyl-D-aspartate receptor. J Neurochem. 1991 Sep; 57(3):811-8.
    View in: PubMed
    Score: 0.005
  7. Regulation of subtypes of beta-adrenergic receptors in rat brain following treatment with 6-hydroxydopamine. J Neurosci. 1989 Jul; 9(7):2297-305.
    View in: PubMed
    Score: 0.004
  8. Effect of exercise duration on density and coupling of beta-adrenergic receptors on human mononuclear cells. J Appl Physiol (1985). 1989 Mar; 66(3):1494-500.
    View in: PubMed
    Score: 0.004
  9. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse. 1989; 3(1):74-82.
    View in: PubMed
    Score: 0.004
  10. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum. J Pharmacol Exp Ther. 1988 Mar; 244(3):987-93.
    View in: PubMed
    Score: 0.004
  11. Endogenous modulators of binding of [3H]nitrendipine in extracts of rat brain. J Pharmacol Exp Ther. 1988 Mar; 244(3):971-6.
    View in: PubMed
    Score: 0.004
  12. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci. 1986 Nov; 6(11):3177-88.
    View in: PubMed
    Score: 0.004
  13. Adenylate kinase increases adenylate cyclase activity in membranes from rat lung. J Cyclic Nucleotide Protein Phosphor Res. 1986; 11(1):63-73.
    View in: PubMed
    Score: 0.004
  14. Differential effects of cytosolic modulators of fluoride-stimulated adenylate cyclase activity in striatum and cerebral cortex. Alcohol Drug Res. 1985-1986; 6(6):379-86.
    View in: PubMed
    Score: 0.003
  15. Assay of dopamine receptors with [alpha-3H]flupenthixol. J Pharmacol Exp Ther. 1985 Jan; 232(1):57-61.
    View in: PubMed
    Score: 0.003
  16. Multiple sites of action of ethanol on adenylate cyclase. J Pharmacol Exp Ther. 1983 Dec; 227(3):551-6.
    View in: PubMed
    Score: 0.003
  17. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. Eur J Pharmacol. 2003 Jul 04; 472(1-2):89-97.
    View in: PubMed
    Score: 0.003
  18. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum. Mol Pharmacol. 1983 Mar; 23(2):303-9.
    View in: PubMed
    Score: 0.003
  19. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. J Pharmacol Exp Ther. 1983 Jan; 224(1):1-6.
    View in: PubMed
    Score: 0.003
  20. Selective changes in the density of beta 1-adrenergic receptors in rat striatum following chronic drug treatment and adrenalectomy. Brain Res. 1982 Dec 09; 252(2):309-14.
    View in: PubMed
    Score: 0.003
  21. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum. Proc Natl Acad Sci U S A. 1982 Dec; 79(23):7561-5.
    View in: PubMed
    Score: 0.003
  22. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J Pharmacol Exp Ther. 1982 May; 221(2):439-43.
    View in: PubMed
    Score: 0.003
  23. Effects of magnesium and N-ethylmaleimide on the binding of 3H-hydroxybenzylisoproterenol to beta-adrenergic receptors. J Biol Chem. 1982 Jan 25; 257(2):804-10.
    View in: PubMed
    Score: 0.003
  24. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res. 1981 May 04; 211(2):315-27.
    View in: PubMed
    Score: 0.003
  25. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation. Mol Pharmacol. 1981 May; 19(3):372-8.
    View in: PubMed
    Score: 0.003
  26. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med. 2001 Apr; 7(4):471-7.
    View in: PubMed
    Score: 0.003
  27. Effects of hypoxia on density of beta-adrenergic receptors. J Appl Physiol Respir Environ Exerc Physiol. 1981 Feb; 50(2):363-6.
    View in: PubMed
    Score: 0.002
  28. Activation of adenylate cyclase by ethanol in mouse striatal tissue. J Pharmacol Exp Ther. 1981 Jan; 216(1):129-34.
    View in: PubMed
    Score: 0.002
  29. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors. Mol Pharmacol. 1980 Nov; 18(3):341-7.
    View in: PubMed
    Score: 0.002
  30. Alterations in beta 1- and beta 2-adrenergic receptor density in the cerebellum of aging rats. J Neurochem. 1980 Jul; 35(1):273-5.
    View in: PubMed
    Score: 0.002
  31. Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. J Pharmacol Exp Ther. 1980 Jun; 213(3):491-6.
    View in: PubMed
    Score: 0.002
  32. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980 May; 65(5):949-57.
    View in: PubMed
    Score: 0.002
  33. Brain neurotransmitter receptor systems in mice genetically selected for differences in sensitivity to ethanol. Pharmacol Biochem Behav. 1980 Apr; 12(4):509-13.
    View in: PubMed
    Score: 0.002
  34. Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. J Pharmacol Exp Ther. 1980 Mar; 212(3):503-8.
    View in: PubMed
    Score: 0.002
  35. Brain neurotransmitter receptor systems in alcohol treated mice and in mice genetically selected for differences in sensitivity to alcohol. Adv Exp Med Biol. 1980; 132:787-95.
    View in: PubMed
    Score: 0.002
  36. Characterization of radiolabeled agonist binding to beta-adrenergic receptors in mammalian tissues. J Cyclic Nucleotide Res. 1980; 6(3):217-30.
    View in: PubMed
    Score: 0.002
  37. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration. Brain Res. 1979 Dec 14; 178(2-3):589-95.
    View in: PubMed
    Score: 0.002
  38. Comparison of beta adrenergic receptor subtypes in mammalian tissues. J Pharmacol Exp Ther. 1979 Dec; 211(3):502-8.
    View in: PubMed
    Score: 0.002
  39. Agonist-induced changes in beta adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex. J Pharmacol Exp Ther. 1979 Sep; 210(3):433-9.
    View in: PubMed
    Score: 0.002
  40. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain. J Pharmacol Exp Ther. 1979 Aug; 210(2):215-21.
    View in: PubMed
    Score: 0.002
  41. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol. 1979 Jul; 16(1):21-33.
    View in: PubMed
    Score: 0.002
  42. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979 Jul; 16(1):34-46.
    View in: PubMed
    Score: 0.002
  43. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther. 1978 Nov; 207(2):446-57.
    View in: PubMed
    Score: 0.002
  44. Adrenergic storage vesicles in rat heart: quantitation of membrane-bound and membrane-enclosed dopamine beta-hydroxylase. J Pharmacol Exp Ther. 1978 May; 205(2):357-65.
    View in: PubMed
    Score: 0.002
  45. Regulation of beta-adrenergic receptors in the cerebral cortex. Adv Cyclic Nucleotide Res. 1978; 9:465-83.
    View in: PubMed
    Score: 0.002
  46. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses. Mol Pharmacol. 1977 Nov; 13(6):1170-80.
    View in: PubMed
    Score: 0.002
  47. Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme. J Pharmacol Exp Ther. 1977 Sep; 202(3):590-600.
    View in: PubMed
    Score: 0.002
  48. Differential effects of nerve impulses on adrenergic storage vesicles in rat heart. J Pharmacol Exp Ther. 1976 Jul; 198(1):112-22.
    View in: PubMed
    Score: 0.002
  49. Endogenous inhibitors of dopamine-beta- hydroxylase in rat organs. Biochem Pharmacol. 1976 May 15; 25(10):1167-74.
    View in: PubMed
    Score: 0.002
  50. Distribution and properties of adrenergic storage vesicles in nerve terminals. J Pharmacol Exp Ther. 1976 Feb; 196(2):346-59.
    View in: PubMed
    Score: 0.002
  51. Occurrence, transport, and storage of octopamine in human thrombocytes. Clin Pharmacol Ther. 1975 Nov; 18(5 Pt 1):587-93.
    View in: PubMed
    Score: 0.002
  52. Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec; 350(6):611-7.
    View in: PubMed
    Score: 0.002
  53. The normal occurrence of octopamine in neural tissue of the Octopus and other cephalopods. J Neurochem. 1974 Feb; 22(2):271-80.
    View in: PubMed
    Score: 0.002
  54. Distribution and turnover of octopamine in tissues. J Neurochem. 1972 Jan; 19(1):157-63.
    View in: PubMed
    Score: 0.001
  55. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry. Anat Rec. 1991 Dec; 231(4):548-58.
    View in: PubMed
    Score: 0.001
  56. A sensitive enzymatic assay for dopamine- -hydroxylase. J Pharmacol Exp Ther. 1971 Sep; 178(3):425-31.
    View in: PubMed
    Score: 0.001
  57. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res. 1991 Jun 21; 60(2):161-77.
    View in: PubMed
    Score: 0.001
  58. Neurally mediated increase in dopamine-beta-hydroxylase activity. Proc Natl Acad Sci U S A. 1970 Jun; 66(2):453-8.
    View in: PubMed
    Score: 0.001
  59. An enzymatic assay for octopamine and other beta-hydroxylated phenylethylamines. J Pharmacol Exp Ther. 1969 Dec; 170(2):253-61.
    View in: PubMed
    Score: 0.001
  60. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients. Circulation. 1989 Oct; 80(4):903-14.
    View in: PubMed
    Score: 0.001
  61. Octopamine: normal occurrence in sympathetic nerves of rats. Science. 1969 Apr 25; 164(3878):428-9.
    View in: PubMed
    Score: 0.001
  62. Characterization of lymphocyte beta-adrenergic receptors at rest and during exercise in ambulatory patients with chronic congestive heart failure. Am J Cardiol. 1989 Feb 01; 63(5):307-12.
    View in: PubMed
    Score: 0.001
  63. Comparison of 125I-SCH 23982 and [3H]SCH 23390 as ligands for the D-1 dopamine receptor. J Neurochem. 1988 Aug; 51(2):391-7.
    View in: PubMed
    Score: 0.001
  64. Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldosterone, and lymphocyte beta-adrenoceptor density. J Cardiovasc Pharmacol. 1988 Apr; 11(4):413-23.
    View in: PubMed
    Score: 0.001
  65. Genetic influence on the regulation of beta adrenergic receptors in mice. J Pharmacol Exp Ther. 1986 Jan; 236(1):24-9.
    View in: PubMed
    Score: 0.001
  66. Effect of central catecholamine depletion on the osmotic and nonosmotic stimulation of vasopressin (antidiuretic hormone) in the rat. J Clin Invest. 1979 Dec; 64(6):1599-607.
    View in: PubMed
    Score: 0.001
  67. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. J Pharmacol Exp Ther. 1977 Sep; 202(3):544-57.
    View in: PubMed
    Score: 0.000
  68. Induction of dopamine- -hydroxylase in rat superior cervical ganglia in organ culture. J Neurochem. 1972 Mar; 19(3):919-21.
    View in: PubMed
    Score: 0.000
  69. Electrophoretic properties of dopamine -hydroxylase in several tissues from three species. Mol Pharmacol. 1972 Jan; 8(1):50-8.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.